Related Experiment Videos
Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease
A T Van Oosterom1, E A De Smedt, L J Denis
1Department of Oncology, Antwerp University Hospital, Edegem, Belgium.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Paediatric sclerotherapy of vascular anomalies of the hand and digits.
Clinical radiology·2025
Failure of total hypophysectomy to remove intrasellar microadenoma in cushing's disease.
Endocrine pathology·2020
Attitudes towards interprofessional collaboration in young healthcare professionals.
Journal of interprofessional care·2019
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.
Pharmacological research·2026
Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.
ACS chemical biology·2026